Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    "Congenital antithrombin deficiency"
Show Display Options
RSS Create an RSS feed from your search for:
"Congenital antithrombin deficiency"
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed A Study of KW-3357 in Congenital Antithrombin Deficiency
Condition: Congenital Antithrombin Deficiency
Intervention: Drug: KW-3357
2 Completed
Has Results
Assess Incidence of Deep Vein Thrombosis(DVT)Following Administration of Recombinant Human Antithrombin (rhAT) to Hereditary Antithrombin(AT) Deficient Patients in High Risk Situations.
Condition: Antithrombin Deficiency, Congenital
Intervention: Biological: Recombinant Human Antithrombin (rhAT)
3 Completed
Has Results
Recombinant Human Antithrombin (rhAT) in Patients With Hereditary Antithrombin Deficiency Undergoing Surgery or Delivery
Condition: Antithrombin III Deficiency
Intervention: Biological: Recombinant human antithrombin (rhAT)

Indicates status has not been verified in more than two years